Evaluation of efficacy and safety of chemotherapy in the treatment of recurrent or resistant gestational trophoblastic neoplasia A protocol for systematic review and meta-analysis

被引:0
作者
Luo, Fang [1 ]
Li, Li [2 ]
Gao, Qing [1 ]
Li, Yu-Xia [3 ]
机构
[1] Wuhan Puren Hosp, Dept Gynecol, Wuhan, Hubei, Peoples R China
[2] Wuhan Puren Hosp, Dept Pathol, Wuhan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Wuhan Maternal & Child Healthcare Hosp, Wuhan Childrens Hospita, Tongji Med Coll,Dept Gynaecol & Obstet, Wuhan 430019, Hubei, Peoples R China
关键词
chemotherapy; effectiveness; efficacy; gestational trophoblastic neoplasia; meta-analysis; recurrent; resistant; safety; MANAGEMENT; RISK; METASTASES; SURVIVAL; UPDATE;
D O I
10.1097/MD.0000000000027320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Gestational Trophoblastic Neoplasia (GTN) is a spectrum of pregnancy-associated tumours emerging from placental tissue. Generally, GTN patients are considered to have a high rate of recovery. However, almost 25 per cent of GTN tumours resist, or have a high probability of relapsing following the first line of chemo treatment. Thus, tumours that resist or relapse requires salvage chemotherapy, sometimes accompanied by surgery. Globally, clinicians utilize a range of salvage regimens. Currently, ongoing debates are centred around choosing the best regimens in terms of safety and efficacy. Therefore, the current research aims to appraise the success and level of safeness using chemotherapy to treat patients with resistant or recurrent GTN. Methods: The authors will conduct a methodological exploration in online-based databases to find Randomized Controlled Trials related to the adoption of chemotherapy agents as treatment for resistant or recurrent GTN patients. The databases are as follows: EMBASE, PubMed, Cochrane Database Central, UpToDate, Chinese National Knowledge Infrastructure, Web of Science, and WanFang Database. The search will be limited to articles published in either English or Chinese. Moreover, the authors will also perform a search for ongoing trials on online-based clinical trial registries. Two independent authors will screen and select articles for review. A similar process will be followed by two independent authors to complete the extraction of data and evaluate the bias risk. In relevant cases, the authors will contract trial investigators to obtain related, unpublished data. The authors will use the random-effects model for pooling data in RevMan software (v5.3). Results: The present systematic review aims to evaluate the efficacy and level of safeness associated with using chemotherapy for resistant or recurrent GTN patients. Conclusion: The results of the proposed systematic analysis could summarize the most recent evidence for the use of chemotherapy agents on GTN patients. Ethics and dissemination: Since the proposed study uses pre-published data, an ethical approval is not required.
引用
收藏
页数:4
相关论文
共 20 条
  • [1] Gestational Trophoblastic Neoplasia, Version 2.2019
    Abu-Rustum, Nadeem R.
    Yashar, Catheryn M.
    Bean, Sarah
    Bradley, Kristin
    Campos, Susana M.
    Chon, Hye Sook
    Chu, Christina
    Cohn, David
    Crispens, Marta Ann
    Damast, Shari
    Dorigo, Oliver
    Eifel, Patricia J.
    Fisher, Christine M.
    Frederick, Peter
    Gaffney, David K.
    Han, Ernest
    Huh, Warner K.
    Lurain, John R., III
    Mariani, Andrea
    Mutch, David
    Nagel, Christa
    Nekhlyudov, Larissa
    Fader, Amanda Nickles
    Remmenga, Steven W.
    Reynolds, R. Kevin
    Sisodia, Rachel
    Tillmanns, Todd
    Ueda, Stefanie
    Wyse, Emily
    McMillian, Nicole R.
    Scavone, Jillian
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (11): : 1374 - 1391
  • [2] Agarwal R, 2014, J REPROD MED, V59, P7
  • [3] Ahamed E, 2012, J REPROD MED, V57, P262
  • [4] [Anonymous], 2009, INT J GYNECOL OBSTET, V105, P3
  • [5] Molar Pregnancy
    Berkowitz, Ross S.
    Goldstein, Donald P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (16) : 1639 - 1645
  • [6] Following chemotherapy for gestational trophoblastic neoplasia, do residual lung lesions increase the risk of relapse?
    Bouchard-Fortier, Genevieve
    Ghorani, Ehsan
    Short, Dee
    Aguiar, Xianne
    Harvey, Richard
    Unsworth, Nick
    Kaur, Baljeet
    Sarwar, Naveed
    Seckl, Michael J.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 158 (03) : 698 - 701
  • [7] Cancer N, 2009, COMMON TERMINOLOGY C
  • [8] Meta-analysis in clinical trials revisited
    DerSimonian, Rebecca
    Laird, Nan
    [J]. CONTEMPORARY CLINICAL TRIALS, 2015, 45 : 139 - 145
  • [9] State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia
    Elias, Kevin M.
    Berkowitz, Ross S.
    Horowitz, Neil S.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (11): : 1396 - 1401
  • [10] Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study
    Frijstein, M. M.
    Lok, C. A. R.
    van Trommel, N. E.
    ten Kate-Booij, M. J.
    Massuger, L. F. A. G.
    van Werkhoven, E.
    Short, D.
    Aguiar, X.
    Fisher, R. A.
    Kaur, B.
    Sarwar, N.
    Sebire, N. J.
    Seckl, M. J.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (03) : 389 - 395